A simplified similarity-based approach for drug-drug interaction prediction.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
07
2023
accepted:
17
10
2023
medline:
13
11
2023
pubmed:
9
11
2023
entrez:
9
11
2023
Statut:
epublish
Résumé
Drug-drug interactions (DDIs) are a critical component of drug safety surveillance. Laboratory studies aimed at detecting DDIs are typically difficult, expensive, and time-consuming; therefore, developing in-silico methods is critical. Machine learning-based approaches for DDI prediction have been developed; however, in many cases, their ability to achieve high accuracy relies on data only available towards the end of the molecule lifecycle. Here, we propose a simple yet effective similarity-based method for preclinical DDI prediction where only the chemical structure is available. We test the model on new, unseen drugs. To focus on the preclinical problem setting, we conducted a retrospective analysis and tested the models on drugs that were added to a later version of the DrugBank database. We extend an existing method, adjacency matrix factorization with propagation (AMFP), to support unseen molecules by applying a new lookup mechanism to the drugs' chemical structure, lookup adjacency matrix factorization with propagation (LAMFP). We show that using an ensemble of different similarity measures improves the results. We also demonstrate that Chemprop, a message-passing neural network, can be used for DDI prediction. In computational experiments, LAMFP results in high accuracy, with an area under the receiver operating characteristic curve of 0.82 for interactions involving a new drug and an existing drug and for interactions involving only existing drugs. Moreover, LAMFP outperforms state-of-the-art, complex graph neural network DDI prediction methods.
Identifiants
pubmed: 37943768
doi: 10.1371/journal.pone.0293629
pii: PONE-D-23-20500
pmc: PMC10635435
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0293629Informations de copyright
Copyright: © 2023 Shtar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Clin Pharmacol. 1999 Feb;54(12):959-63
pubmed: 10192758
BMC Bioinformatics. 2017 Jan 5;18(1):18
pubmed: 28056782
JAMA. 1998 Jul 8;280(2):157-8
pubmed: 9669789
Methods. 2020 Jul 1;179:37-46
pubmed: 32497603
Bioinformatics. 2022 Jan 27;38(4):1102-1109
pubmed: 34791058
J Chem Inf Model. 2019 Aug 26;59(8):3370-3388
pubmed: 31361484
Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4304-E4311
pubmed: 29666228
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Bioinformatics. 2020 Aug 1;36(15):4316-4322
pubmed: 32407508
Brief Bioinform. 2021 Nov 5;22(6):
pubmed: 33951725
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
BMC Bioinformatics. 2016 Mar 18;17:128
pubmed: 26987649
Brief Bioinform. 2021 Jul 20;22(4):
pubmed: 33147616
JAMA. 2006 Oct 18;296(15):1858-66
pubmed: 17047216
Antimicrob Agents Chemother. 1998 May;42(5):1139-45
pubmed: 9593141
Nat Commun. 2020 Sep 11;11(1):4575
pubmed: 32917868
Soc Sci Med. 2002 Aug;55(3):497-507
pubmed: 12144155
Cell. 2020 Feb 20;180(4):688-702.e13
pubmed: 32084340
IEEE/ACM Trans Comput Biol Bioinform. 2022 Jul-Aug;19(4):1968-1985
pubmed: 34003753
PLoS One. 2019 Aug 1;14(8):e0219796
pubmed: 31369568